Zetesis Scientific Due Diligence

Due diligence on a high-dimensional scientific claim, graded dimension by dimension against the published record. Covers genomics and Mendelian randomisation, single-cell, bulk omics, CRISPR screens, clinical trials, real-world evidence, AI clinical decision support, diagnostics, preclinical models, cell and gene therapy, and structural biology. Returns the questions a domain reviewer would ask, the failure patterns that caught comparable claims before, and evidence from Europe PMC, ClinicalTrials.gov, openFDA, NIH RePORTER and SEC EDGAR with a hard identifier on every source, checked against retraction notices. Retrieval can be fenced to a year, so a claim is judged on what was knowable then.